Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides In Situ

Cancer Research

Volumn 72, Issue 22, 2012, Pages 5956-5965

  Liu, Wenge ^a   McDaniel, Jonathan ^a   Li, Xinghai ^a,c   Asai, Daisuke ^a   Quiroz, Felipe Garcia ^a   Schaal, Jeffery ^a   Park, Ji Sun ^a   Zalutsky, Michael ^b   Chilkoti, Ashutosh ^a  

^a Duke University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN LIKE POLYPEPTIDE; INDIUM; INDIUM 131; POLYPEPTIDE; RADIOACTIVE SEED; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRACHYTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOACTIVITY; SURVIVAL RATE; SURVIVAL TIME; TRANSITION TEMPERATURE; TUMOR XENOGRAFT;

ANIMALS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ELASTIN; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PEPTIDES; PROSTATIC NEOPLASMS; TANDEM REPEAT SEQUENCES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84869216639     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-2127     Document Type: Article

References (20)

1. Blasko JC, Mate T, Sylvester JE, Grimm PD, Cavanagh W. Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes. Semin Radiat Oncol 2002;12:81.
2. Ragde H, Korb LJ, Elgamal AA, Grado GL, Nadir BS. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 2000;89:135-41.
3. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol 2000;57:273-8.
4. Woolsey J, Miller N, Theodorescu D. Permanent interstitial brachytherapy for prostate cancer: a current review. World J Urol 2003;21:209-19.
5. Older RA, Synder B, Krupski TL, Glembocki DJ, Gillenwater JY. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy. J Urol 2001;165:1590-2.
6. Hruby M, Konak C, Kucka J, Vetrik M, Filippov SK, Vetvicka D, et al. Thermoresponsive, hydrolytically degradable polymer micelles intended for radionuclide delivery. Macromol Biosci 2009;9:1016-27.
7. Hrycushko BA, Li S, Goins B, Otto RA, Bao A. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution. Med Phys 2011;38:1339-47.
8. Yuan J, You Y, Lu X, Muzik O, Oupicky D, Peng F. Synthesis of Poly[APMA]-DOTA-64Cu conjugates for interventional radionuclide therapy of prostate cancer: assessment of intratumoral retention by micro-positron emission tomography. Mol Imaging 2007;6:10-7.
9. Hruby M, Pouckova P, Zadinova M, Kucka J, Lebeda O. Thermoresponsive polymeric radionuclide delivery system-an injectable brachytherapy. Eur J Pharm Sci 2011;42:484-8.
10. Meyer DE, Chilkoti A. Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 2002;3:357-67.
11. Chilkoti A, Dreher MR, Meyer DE, Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 2002;54:613-30.
12. Chilkoti A, Dreher MR, Meyer DE. Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Deliv Rev 2002;54:1093-111.
13. Liu W, Dreher RM, Furgeson DY, Peixoto VK, Yuan H, Zalutsky MR, et al. Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice. J Control Release 2006;116:170-8.
14. Liu W, Dreher MR, Chow DC, Zalutsky MR, Chilkoti A. Tracking the in vivo fate of recombinant polypeptides by isotopic labeling. J Control Release 2006;114:184-92.
15. McDaniel JR, Callahan DJ, Chilkoti A. Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliv Rev 2010;62:1456-67.
16. Liu W, MacKay JA, Dreher MR, Chen M, McDaniel JR, Simnick AJ, et al. Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model. J Control Release 2010;144:2-9.
17. McDaniel JR, MacKay JA, Quiroz FG, Chilkoti A. Recursive directional ligation by plasmid reconstruction allows rapid and seamless cloning of oligomeric genes. Biomacromolecules 2010;11:944-52.
18. Meyer DE, Trabbic-Carlson K, Chilkoti A. Protein purification by fusion with an environmentally responsive elastin-like polypeptide: effect of polypeptide length on the puri fication of thioredoxin. Biotechnol Prog 2001;17:720-8.
19. Trabbic-Carlson K, Meyer DE, Liu L, Piervincenzi R, Nath N, LaBean T, et al. Effect of protein fusion on the transition temperature of an environmentally responsive elastin-like polypeptide: a role for surface hydrophobicity? Protein Eng Des Sel 2004;17:57-66.
20. Zweit J. Radionuclides and carrier molecules for therapy. Phys Med Biol 1996;41:1905-14.